Matthew Samec is a Rheumatology/Immunology physician. OpenAlex indexes 13 publications with 287 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
901 Montgomery St
Decorah, IA 521012325
Telephone
563-382-2911Provider last certified this registry record 16 Jul 2025.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
57.2%TNF inhibitor50%Certolizumab pegol65%Golimumab27%Infliximab8%Enbrel Sureclick0%Humira(Cf)0%Cyltezo(Cf) Pen0%Enbrel0%Part D + Part B<11 patientsSelective T Cell Costimulation Modulator6.7%Abatacept100%Part B, office-administered≥13 patients+ 3 more classes in this area
Musculoskeletal
39.4%Other drugs affecting bone structure and mineralization32%Romosozumab-aqqg100%Part B, office-administered≥29 patientsRANK Ligand Inhibitor6.7%Denosumab100%Part B, office-administered≥47 patients+ 4 more classes in this area
Dermatology
2.3%Corticosteroid2.3%Methylprednisolone acetate93%Triamcinolone acetonide7%Part B, office-administered≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Use of Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay in Outpatient Rheumatology Practice
The Journal of Rheumatology
2025 - Clinical phenotype, NOD2 genotypes, and treatment observations in Yao syndrome: a retrospective case series
Frontiers in Immunology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”